Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload

NCT06468423 is registered in ClinicalTrials.gov with RESnTEC, Institute of Research as lead sponsor.

NCT NCT06468423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06468423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload
Lead sponsor
RESnTEC, Institute of Research
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2023
Completion date
September 30, 2023
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pateints of β-thalassemia major with iron overload